Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan · Delayed Price · Currency is TWD 62.70
-0.20 (-0.32%)
Aug 12, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Neuromuscular System Medication | 136.28M | Log In | Log In | Log In | Log In | Upgrade |
Neuromuscular System Medication Growth | 16.75% | Log In | Log In | Log In | Log In | Upgrade |
Other Formulations | 80.80M | Log In | Log In | Log In | Log In | Upgrade |
Other Formulations Growth | 25.97% | Log In | Log In | Log In | Log In | Upgrade |
Anti-inflammatory, Analgesic and Anti-allergic | 72.40M | Log In | Log In | Log In | Log In | Upgrade |
Anti-inflammatory, Analgesic and Anti-allergic Growth | 20.57% | Log In | Log In | Log In | Log In | Upgrade |
Gastrointestinal Tract Hepatobiliary System | 70.50M | Log In | Log In | Log In | Log In | Upgrade |
Gastrointestinal Tract Hepatobiliary System Growth | 24.23% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Drug | 69.49M | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Drug Growth | 33.56% | Log In | Log In | Log In | Log In | Upgrade |
Respiratory Tract Medications | 49.92M | Log In | Log In | Log In | Log In | Upgrade |
Respiratory Tract Medications Growth | 55.57% | Log In | Log In | Log In | Log In | Upgrade |
Endocrine System Medicine | 41.96M | Log In | Log In | Log In | Log In | Upgrade |
Endocrine System Medicine Growth | 8.78% | Log In | Log In | Log In | Log In | Upgrade |
Urinary System Medications | 34.54M | Log In | Log In | Log In | Log In | Upgrade |
Urinary System Medications Growth | 17.83% | Log In | Log In | Log In | Log In | Upgrade |
Vitamins and Minerals | 30.26M | Log In | Log In | Log In | Log In | Upgrade |
Vitamins and Minerals Growth | 11.18% | Log In | Log In | Log In | Log In | Upgrade |
Other | 20.55M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 15.65% | Log In | Log In | Log In | Log In | Upgrade |
Chemotherapeutic Agents | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandise | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandise Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Taiwan | 605.44M | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | 22.47% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 1.27M | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | 310.36% | Log In | Log In | Log In | Log In | Upgrade |